
Membership | Public Reports | Settlement Overview | Use of ORF Funds
About
Maryland’s Opioid Restitution Fund (ORF) was created in 2019 to receive all funds awarded to the State of Maryland through legal settlements with prescription opioid manufacturers and distributors. In 2022, Maryland established the ORF Advisory Council to provide recommendations regarding the use of those funds. For questions regarding the Advisory Council, email Help.OOCC@Maryland.gov.
Resources
- State-Subdivision Agreement (Janssen)
- Janssen Settlement – Exhibit E (allowable uses)
- Legislative Mandate (House Bill 794 of 2022)
- 2023 ORF Advisory Council Funding Reccomendations
Vacancy Announcement
The Opioid Restitution Fund Advisory Council is currently accepting applications to fill two membership vacancies beginning in 2024. By law, the ORF Advisory Council is required to have broad representation from individuals with diverse backgrounds. You can read more about the responsibilities of the council and its membership requirements at https://mgaleg.maryland.gov/mgawebsite/Laws/StatuteText?article=gsf§ion=7-331&enactments=false.
If you are interested in serving on the ORF Advisory Council, please see the vacancy details below.
Current Openings:
Secretary of Health Appointment
- An individual who is in recovery from a substance use disorder
To apply for this vacancy, please complete and return the forms below AND a resume to michelle.morningred@maryland.gov.
Governor’s Appointment
- An individual who represents a community-based opioid treatment program.
To apply for this vacancy, please complete the online application through the Governor’s Appointments Office here: https://md.accessgov.com/governors-office/Forms/Page/v2/profile/1
Upcoming Meetings
Next Regular Meeting: to be announced.
Past Meetings
Regular Meeting – Monday, October 2, 2023 (virtual)
Agenda | Minutes (pending approval)
Click here to view meeting minutes from past ORF Advisory Council meetings.
Stay in Contact!
To receive notifications regarding the ORF Advisory Council, please complete the following form to be added to our mailing list.